Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
about
Dietary folate intake and modification of the association of urinary bisphenol A concentrations with in vitro fertilization outcomes among women from a fertility clinicComparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: A systematic review and meta-analysisPharmacokinetic, pharmacodynamic, and clinical aspects of ovulation induction agents: A review of the literatureEfficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysis.Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews.Reassessing the feasibility of the zygote score for predicting embryo viability in IVF/ICSI using the GnRH antagonist protocol compared to the long protocolIncreased Uterine NK cell numbers and perforin expression during the implantation phase in IVF Cycles with GnRH Antagonist Protocol.Pretreatment of normal responders in fresh in vitro fertilization cycles: A comparison of transdermal estradiol and oral contraceptive pills.Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.Polycystic ovary syndrome throughout a woman's life.Reduction of the cetrorelix dose in a multiple-dose antagonist protocol and its impact on pregnancy rate and affordability: A randomized controlled multicenter study.A Proof-of-Concept Clinical Trial of A Single Luteal Use of Long-Acting Gonadotropin-Releasing Hormone Antagonist Degarelix in Controlled Ovarian Stimulation for In Vitro Fertilization: Long Antagonist Protocol.An extremely patient-friendly and efficient stimulation protocol for assisted reproductive technology in normal and high responders.Testicular sperm is superior to ejaculated sperm for ICSI in cryptozoospermia: An update systematic review and meta-analysis.Glomerular Disease in Women.Luteinizing Hormone Receptor Gene and Regulator of G-protein Signaling 2 Gene Expression Level and Association with Oocyte Maturity in In vitro Fertilization/Intracytoplasmic Sperm Injection Cycle.GnRH Antagonist Improves Pubertal Cyclophosphamide-Induced Long-Term Testicular Injury in Adult Rats.Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trialDelayed Start Protocol with Gonadotropin-releasing Hormone Antagonist in Poor Responders Undergoing In Vitro Fertilization: A Randomized, Double-blinded, Clinical TrialEarly gonadotropin-releasing hormone antagonist protocol in women with polycystic ovary syndrome: A preliminary randomized trial
P2860
Q28391777-852155AF-79B5-494F-B16D-247EC15D41FAQ33596777-92500765-37AA-44D9-9772-067CE5BD1062Q33743109-0B4BC4C9-AD94-4639-939E-317CD7362393Q33747432-6DE05BD6-E89A-43DF-A539-812D3C4C3819Q36256879-A26358A1-323D-44BA-9AB1-35452EC8757AQ36267719-152B26C0-281E-4A28-BCAB-3EEB25DED062Q37550317-A0CCE4A9-A4CB-47B7-A7C8-C7626327F536Q37585144-4A384054-CC6E-48DA-9094-45F7A779A7AFQ38602011-C5E4C69B-5AF2-492E-A915-4C6A5F5EF66BQ38765739-29492696-6252-4DCD-A718-92DBF160CE16Q47449419-8803FE6A-4981-412F-BD0B-A8D6C765DD3CQ47915318-1C8E7961-C5D6-4A40-9B01-051637BA024FQ48502507-EFC16AFC-E17A-4864-923E-61BD99524346Q52653133-0B4F0560-3B2E-4396-8D36-808A31B93469Q52728816-6FC9E3EC-EE6F-4E68-8DDB-42F1815A9D4DQ54966369-153D0659-F048-48DD-A76F-FED5F2DF7F3CQ54994281-D0519405-60E1-4A4A-AA15-04F30ACFCA01Q55400274-18036DF1-3B05-4B37-9603-9D14B6960D68Q55500197-6553671D-64B5-4584-96CF-E8ADA6F9E299Q56341935-A054AD95-79C1-4142-B730-EABB5AE7884CQ58571823-4555B246-D156-4193-BDCA-EA19B6A21422Q58767959-716128BE-7FDF-49AD-BFCE-DC87A78544C7
P2860
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
@ast
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
@en
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
@en-gb
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
@nl
type
label
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
@ast
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
@en
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
@en-gb
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
@nl
prefLabel
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
@ast
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
@en
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
@en-gb
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
@nl
P2093
P2860
P1476
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
@en
P2093
Frank J Broekmans
Hesham G Al-Inany
Julie Brown
Mohamed A Youssef
Reuben Olugbenga Ayeleke
Wai Sun Lam
P2860
P356
10.1002/14651858.CD001750.PUB4
P577
2016-04-29T00:00:00Z